1417287-40-1

Basic information

• Product Name: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide
• Synonyms: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide;(r)-3-boc-4-ethyl-2,2-dioxo-[1,2,3]oxathiazolidine;(R)-3-Boc-4-ethyl-1,2,3-oxathiazolidine 2,2-dioxide
• CAS NO: 1417287-40-1
• Molecular Formula: C₉H₁₇NO₅S
• Molecular Weight: 251.29998
• Mol File: 1417287-40-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide(1417287-40-1)
• EPA Substance Registry System: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide(1417287-40-1)

Safety Data

• Hazardous Substances Data: 1417287-40-1(Hazardous Substances Data)

Usage

General Description

(R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide is a chemical compound with the molecular formula C9H17NO4S. It is a white, crystalline solid with a molecular weight of 231.3 g/mol. (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide is used in the pharmaceutical industry as a chiral building block in the synthesis of various biologically active molecules. It is also used as a reagent in organic synthesis and can act as a stereoselective catalyst in certain chemical reactions. Additionally, (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide has potential applications in the development of new drugs and pharmaceutical products.

Relevant articles and documents

Synthesis method for tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compound

The invention relates to a synthesis method for a tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compound. The tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compoundhas a structural formula as shown in a formula I which is described in the specification. The synthesis method comprises the step of allowing a compound as shown in a formula II which is described inthe specification with sulfonyl chloride in the presence of an organic solvent to generate the compound as shown in the formula I. The structural formula of the compound as shown in the formula I andthe structural formula of the compound as shown in the formula II are described in the specification. The synthesis method disclosed by the invention is simple to operate; compared with a conventional published two-step method, the synthesis method provided by the invention only needs one step; and the synthesis method is more convenient, reduces byproducts, is high in yield, does not need to usea catalyst and a highly-toxic substance in the reaction, and is safe and low in cost.